Skip to Primary Navigation

CMS finalizes Medicare Part B drug pricing model to cut costs

A photo of several blue prescription drug capsules in a white pharmacist tray.
Photo: Eric Thayer/Getty Images

CMS finalized a mandatory Medicare Part B payment model using pricing benchmarks to test lower drug costs while maintaining care quality.

To reduce prescription drug costs for certain Original Medicare Part B beneficiaries, the Centers for Medicare & Medicaid Services (CMS) has finalized a new mandatory drug payment model that leverages a revised rebate calculation system.

The new Global Benchmark for Efficient Drug Pricing, or GLOBE, Model will test whether

According

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience